Open Access
Subscription or Fee Access
Dual function of Selenium nanoparticles: Inhibition or induction of lysozyme amyloid aggregation and evaluation of their cell based cytotoxicity
Abstract
Aberrant protein aggregation and the formation of amyloid deposits are associated with numerous neuro- and non-neurodegenerative disorders. Thus, one potential strategy is to eliminate these deposits by halting amyloid aggregation. Selenium nanoparticles (Se-NPs) have great potential in biomedicine for various therapeutic and diagnostic purposes and also have the ability to inhibit amyloid fibrillation. Herein, Hen Egg White Lysozyme (HEWL) was chosen as a protein model, and rod-like Se-NPs with diameters ranging from 90 to 120 nm were synthesized and the influence of shape and concentration of the particles on HEWL fibrillation was investigated. The effect of the nanoparticles on HEWL amyloid formation was analyzed using thioflavin T and Congo red binding assays, atomic force microscopy, and cytotoxicity assays. In the present study, it has been observed that these particles have a dual function in various concentrations. Using lower concentrations of Se-NPs ranging from 3-30 μg/ml, the Thioflavin T (ThT) fluorescence intensity decreased significantly by 60%, with an increased lag time compared to that of the control. While HEWL fibrillation substantially increased upon co-incubation with a higher concentration of these particles (300-2400μg/ml), and these results were verified by AFM, Congo red, and MTT assay. We showed that inhibitory or inductive influences of Se-NPs on the hen egg-white lysozyme (HEWL) amyloid aggregation are achieved via different independent mechanisms. These results demonstrate that dual-activity of Se-NPs might be a valuable targeting system for inhibiting amyloid aggregation, and thus, may play a useful role in new therapeutic and diagnostic strategies for amyloid-related disorders.
Keywords
References
Akiyoshi K., Sasaki Y., Sunamoto J. Molecular chaperone-like activity of hydrogel nanoparticles of hydrophobized pullulan: Thermal stabilization with refolding of carbonic anhydrase B. Bioconjug. Chem., 10: 321-324, 1999.
Alzheimer’s Association. 2015 Alzheimer’s disease facts and figures. Alzheimers Dement., 11: 332–384, 2015.
Azria D., Blanquer S., Verdier J.M., Belamie E. Nanoparticles as contrast agents for brain Nuclear Magnetic Resonance Imaging in Alzheimer Disease diagnosis. J. Mater. Chem. B., 35: 7216–7237, 2017.
Cabaleiro-Lago C., Quinlan-Pluck F., Lynch I., Lindman S., Minogue A.M., Thulin E., Walsh D.M., Dawson K.A., Linse S. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc., 46: 15437-15443, 2008.
Cao A., Hu D., Lai L. Formation of amyloid fibrils from fully reduced hen egg white lysozyme. Protein Sci., 13: 319-324, 2004.
Cardamone M., Puri N. K., Spectrofluorimetric assessment of the surface hydrophobicity of proteins. Biochem. J., 282: 589-593, 1992.
Carlson B.A., Yoo M.H., Shrimali R.K., Irons R., Gladyshev V.N., Hatfield D.L., Park, J.M. Role of selenium-containing proteins in T-cell and macrophage function. Proceedings of the Nutrition Society., 69: 300-310, 2010.
Chakraborty D., Chauhan P., Alex S.A, Chaudhary S., Ethiraj K.R., Chandrasekaran N., Mukherjee A. Comprehensive study on biocorona formation on functionalized and its biological implications. J Mol Liq., 268: 335–342, 2018.
Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu Rev. Biochem, 75: 333-366, 2006.
Chiti F., Dobson C.M. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu Rev Biochem., 86: 27-68, 2017.
Dobson CM. The Amyloid Phenomenon and Its Links with Human Disease. Cold Spring Harb Perspect Biol.,9: a023648, 2017.
De M., Rotello V.M. Synthetic "chaperones": nanoparticle-mediated refolding of thermally
denatured proteins. Chem. Commun., 3504-3506, 2008.
Dehvari M., Ghahghaei A. The effect of green synthesis silver nanoparticles (AgNPs) from Pulicaria undulata on the amyloid formation in α-lactalbumin and the chaperon action of α-casein. Int. j. boil. macromol., 108: 1128-1139, 2018.
Fei L., Perrett S. Effect of Nanoparticles on Protein Folding and Fibrillogenesis. Int J Mol Sci., 10: 646-655, 2009.
Goda S., Takano K., Yamagata Y., Nagata R., Akutsu H., Maki S., Namba K., Yutani K. Amyloid protofilament formation of hen egg lysozyme in highly concentrated ethanol solution. Protein Sci., 9: 369-375, 2000.
Hoeg A., Gogakos A., Murphy E., Mueller S., Köhrle J., Reid D.M., Glüer C.C., Felsenberg D., Roux C., Eastell R., Schomburg L. Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab., 97: 4061-4070, 2012.
Huo X., Zhang Y., Jin X., Li Y., Zhang L. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease. J Photochem Photobiol B ., 190: 98-102, 2019.
Khodarahmi R., Soori H., Amani M. Study of cosolvent-induced α-chymotrypsin fibrillogenesis: does protein surface hydrophobicity trigger early stages of aggregation reaction? The protein journal., 28: p.349, 2009.
Lee C.C., Nayak A., Sethuraman A., Belfort G., McRae G.J. A three-Stage Kinetic Model of Amyloid Fibrillation. Biophys. J., 92: 3448-3458 ,2007.
Liao, Y.H., Chang Y.J., Yoshiike Y., Chang, Y.C., Chen Y.R. Negatively Charged Gold Nanoparticles Inhibit Alzheimer’s Amyloid-β Fibrillization, Induce Fibril Dissociation, and Mitigate Neurotoxicity. Small., 23: 3631−3639, 2012.
Mahmoudi M., Quinlan-Pluck F., Monopoli M.P., Sheibani S., Vali H., Dawson K. A., Lynch I. Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid beta protein fibrillation in solution. ACS Chem. Neurosci., 4: 475−485, 2013.
Malhotra S., Welling M., Mantri S., Desai K. In vitro and in vivo antioxidant, cytotoxic, and anti‐chronic inflammatory arthritic effect of selenium nanoparticles. J Biomed Mater Res B Appl Biomater., 104: 993-1003, 2016.
Mesbahi-Nowrouzi M., Mollania N. Purification of selenate reductase from Alcaligenes sp. CKCr-6A with the ability to biosynthesis of selenium nanoparticle: Enzymatic behavior study in imidazolium based ionic liquids and organic solvent. J Mol Liqu., 29: 1254–1262, 2018.
Morozova-Roche L.A., Zurdo J., Spencer A., Noppe W., Receveur V., Archer D.B., Joniau M., Dobson C.M. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J. Struct. Biol., 130: 339-351, 2000.
Nazýroðlu M., Muhamad S., Pecze L. Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: Focus on selenium nanoparticles. Expert Rev Clin Pharmacol., 10: 773-782, 2017.
Nilsson M.R. Techniques to study amyloid fibril formation in vitro. Methods., 34: 151–160, 2004.
Pepys M.B., Hawkins P.N., Booth D.R., Vigushin D.M., Tennent G.A., Soutar A.K., Totty N., Nguyen O., Blake C.C., Terry C.J. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature., 362: 553–557, 1993.
Ramshini H., Rezaei-Ghaleh N., Ebrahim-Habibi A., Saboury AA., Nemat-Gorgani M. Thermally induced changes in the structure and activity of yeast hexokinase B. Biophys Chem., 137: 88-94, 2008.
Ramshini H., Mannini B., Khodayari K., Ebrahim-Habibi A., Moghaddasi A.S., Tayebee R., Chiti F.Bis(indolyl)phenylmethane derivatives are effective small molecules for inhibition of amyloid fibril formation by hen lysozyme. Eur. J. Med. Chem., 124: 361–371, 2016.
Ramshini H., Moghaddasi A.S., Aldaghi L.S., Mollania N., Ebrahim-Habibi A. Silver nano particles ameliorate learning and spatial memory of male Wistar rats by prevention of amyloid fibril induced neurotoxicity Arch. Ital. Biol., 155: 131-141, 2017.
Ramshini H., Moghaddasi A.S., Mollania N.,Khodarahmi R. Diverse antithetical effects of the bio-compatible Ag-NPs on the hen egg lysozyme amyloid aggregation: from an efficient inhibitor to obscure inducer. J Iran Chem Soc.,16: 33-44, 2019.
Ramshini H., Tayebee R., Bigi A., Bemporad F., Cecchi C., Chiti F. Identification of Novel 1,3,5-Triphenylbenzene Derivative Compounds as Inhibitors of Hen Lysozyme Amyloid Fibril Formation. Int J Mol Sci., 20: p:E5558, 2019.
Saraiva C., Praça C., Ferreira R., Santos T., Ferreira L., Bernardino L. Nanoparticle-mediated Brain Drug Delivery: Overcoming Blood-Brain Barrier to Treat Neurodegenerative Diseases. J Control Release., 235:34-47,2016.
Skalickova S., Milosavljevic V., Cihalova K., Horky P., Richtera L., Adam V.Selenium nanoparticles as a nutritional supplement. Nutrition., 33: 83-90, 2017.
Sophianopoulos A.J., Rhodes C., Holcomb D.N., van Holde K.E. Physical studies of lysozyme. I. Characterization. J. Biol. Chem., 237: 1107–1112, 1962.
Stefani M., Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med., 81: 678-699, 2003.
Wang H., Zhang J., Yu H. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radic Biol Med., 42: 1524- 1533, 2007.
Wang W., Han Y., Fan Y., Wang Y.Effects of Gold Nanospheres and Nanocubes on Amyloid-β Peptide Fibrillation. Langmuir., 35: 2334-2342, 2019.
Walter S., Structure and function of the GroE chaperone. Cell Mol. Life Sci., 59: 1589-1597. 2002.
Wu W.H., Sun X., Yu Y.P., Hu J., Zhao L., Liu Q., Zhao Y.F., Li Y.M. TiO2 Nanoparticles Promote β-amyloid Fibrillation in Vitro. Biochem. Biophys. Res. Commun., 373: 315−318, 2008.
Wu X., Narsimhan, G. Effect of surface concentration on secondary and tertiary conformational
changes of lysozyme adsorbed on silica nanoparticles. Biochim. Biophys. Acta., 1784: 1694-1701, 2008.
Wu X., Narsimhan G. Characterization of secondary and tertiary conformational changes of
beta-lactoglobulin adsorbed on silica nanoparticle surfaces. Langmuir., 24: 4989-4998, 2008.
Xiao L., Zhao D., Chan W.H., Choi M.M.F., Li H.W. Inhibition of Beta 1−40 Amyloid Fibrillation with N-acetyl-L-cysteine Capped Quantum Dots. Biomaterials., 31: 91−98, 2010.
Yazar M., Sarban S., Kocyigit A., Isikan U. Synovial fluid and plasma selenium, copper, zinc, and iron concentrations in patients with rheumatoid arthritis and osteoarthritis. Biol Trace Elem Res., 106: 123-132, 2005.
Young J.C., Agashe V.R., Siegers K., Hartl F.U. Pathways of chaperone-mediated protein
folding in the cytosol. Nat. Rev. Mol. Cell Biol., 5: 781-791, 2004.
Zhang N., Liu Y., Tong L., Xu K., Zhuo L., Tang B. A novel assembly of Au NPs-beta-CDs-FL for the fluorescent probing of cholesterol and its application in blood serum. Analyst.,133: 1176-1181, 2008.
DOI: https://doi.org/10.12871/aib.v159i2.4736
Refbacks
- There are currently no refbacks.